Pharmacotyping provides a precision medicine blueprint for acute lymphoblastic leukemia treatment

In a report published in Nature Medicine, St. Jude scientists examined how ALL cells respond to different therapeutics in the context of their genomic features. This is the most comprehensive study to date describing variations in drug response across genetic ALL subtypes.

Read more: https://www.stjude.org/research/why-st-jude/scientific-report/2024/pharmacotyping-provides-precision-medicine-blueprint-for-acute-lymphoblastic-leukemia-treatment.html